Vitamin D Supplementation and Respiratory Index of Severity in Children (RISC) in Pneumonia
Status:
Completed
Trial end date:
2016-09-01
Target enrollment:
Participant gender:
Summary
Childhood deaths from pneumonia is almost 2000 times higher in developing countries than in
developed countries. In 1970, pneumonia was responsible for 9% of all deaths in children
under 5 years. This rate was 2% in 2007.
Some studies have shown that supplementing with vitamin D reduces disease of the respiratory
tract infection. Some other studies have shown anti-inflammatory effect of vitamin D in cell
lines. Studies about the role of vitamin D supplementation in pneumonia in children are
inadequate to conclude about its role.
The aim of this study is to determine the efficacy of vitamin D supplementation in
Respiratory Index of Severity in Children (RISC) hospitalized clinical outcomes of
hospitalized patients with community-acquired pneumonia.
Phase:
Phase 4
Details
Lead Sponsor:
Hormozgan University of Medical Sciences
Treatments:
Cholecalciferol Ergocalciferols Vitamin D Vitamins